{"transactions":[{"id":4626526,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:27:42.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":515000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option."}],"balance_after":0,"derivative":{"exercise_price":10.24,"expiration_date":"2032-02-24","underlying":"Ordinary Shares","underlying_shares":515000},"source":{"system":"sec-edgar","filing":"0001302443-26-000018","document":"form4-09252026_120938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000130244326000018/form4-09252026_120938.xml","form_type":"4"}},{"id":4626525,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:27:42.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":92567,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 23, 2026, pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated June 28, 2026, by and among the Issuer, Zymeworks Inc. (\"Parent\"), and Zymeworks Merger Sub 1, a wholly owned subsidiary of Parent, the Issuer became a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), pursuant to the Merger Agreement, each ordinary share, par value $0.00001 per share, of the Issuer (\"Ordinary Share\") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive (i) $17.00 in cash, without interest (the \"Per Share Cash Consideration\") and (ii) one contingent value right (a \"CVR\"). Each CVR represents a non-tradeable contractual contingent right to receive cash payments based on the achievement of certain commercial milestones following the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001302443-26-000018","document":"form4-09252026_120938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000130244326000018/form4-09252026_120938.xml","form_type":"4"}},{"id":4626524,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:27:42.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23400,"ownership":{"direct":false,"nature":"As Custodian"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 23, 2026, pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated June 28, 2026, by and among the Issuer, Zymeworks Inc. (\"Parent\"), and Zymeworks Merger Sub 1, a wholly owned subsidiary of Parent, the Issuer became a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), pursuant to the Merger Agreement, each ordinary share, par value $0.00001 per share, of the Issuer (\"Ordinary Share\") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive (i) $17.00 in cash, without interest (the \"Per Share Cash Consideration\") and (ii) one contingent value right (a \"CVR\"). Each CVR represents a non-tradeable contractual contingent right to receive cash payments based on the achievement of certain commercial milestones following the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001302443-26-000018","document":"form4-09252026_120938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000130244326000018/form4-09252026_120938.xml","form_type":"4"}},{"id":4626523,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:27:42.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":76875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As of immediately prior to the Effective Time, each award of performance restricted stock units of the Issuer (a \"Company PSU Award\") that was outstanding as of immediately prior to the Effective Time was cancelled in exchange for the right to receive an amount in cash, without interest, equal to (i) the Per Share Cash Consideration multiplied by (ii) the number of Ordinary Shares with respect to such Company PSU Award that remained outstanding and unreleased as of immediately prior to the Effective Time, plus (iii) one CVR for each Ordinary Share underlying such Company PSU Award."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001302443-26-000018","document":"form4-09252026_120938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000130244326000018/form4-09252026_120938.xml","form_type":"4"}},{"id":4626522,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:27:42.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":151875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, pursuant to the Merger Agreement, each award of restricted stock units of the Issuer (a \"Company RSU Award\") that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the Per Share Cash Consideration multiplied by (ii) the number of Ordinary Shares underlying such Company RSU Award (subject to any required tax withholdings as provided in the Merger Agreement) plus (iii) one CVR for each Ordinary Share underlying such Company RSU Award."}],"balance_after":76875,"source":{"system":"sec-edgar","filing":"0001302443-26-000018","document":"form4-09252026_120938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000130244326000018/form4-09252026_120938.xml","form_type":"4"}},{"id":4626521,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:27:42.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1382272,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 23, 2026, pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated June 28, 2026, by and among the Issuer, Zymeworks Inc. (\"Parent\"), and Zymeworks Merger Sub 1, a wholly owned subsidiary of Parent, the Issuer became a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), pursuant to the Merger Agreement, each ordinary share, par value $0.00001 per share, of the Issuer (\"Ordinary Share\") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive (i) $17.00 in cash, without interest (the \"Per Share Cash Consideration\") and (ii) one contingent value right (a \"CVR\"). Each CVR represents a non-tradeable contractual contingent right to receive cash payments based on the achievement of certain commercial milestones following the Effective Time."}],"balance_after":228750,"source":{"system":"sec-edgar","filing":"0001302443-26-000018","document":"form4-09252026_120938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000130244326000018/form4-09252026_120938.xml","form_type":"4"}},{"id":953,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:06:45.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.6443,"value":3425.0202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9466,"source":{"system":"sec-edgar","filing":"0001302443-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000015/edgardoc.xml","form_type":"4"}},{"id":952,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:06:45.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9480,"source":{"system":"sec-edgar","filing":"0001302443-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000015/edgardoc.xml","form_type":"4"}},{"id":677219,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-08-24T22:09:15.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":20034,"price":16.95,"value":339576.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1611022,"source":{"system":"sec-edgar","filing":"0001302443-26-000012","document":"form4-08242026_100811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000012/form4-08242026_100811.xml","form_type":"4"}},{"id":692948,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:57:14.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":11172,"source":{"system":"sec-edgar","filing":"0001302443-26-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000010/edgardoc.xml","form_type":"4"}},{"id":761539,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-05-27T22:13:08.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":138.08,"expiration_date":"2026-08-10","underlying":"Ordinary Shares","underlying_shares":3415},"source":{"system":"sec-edgar","filing":"0001302443-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000008/edgardoc.xml","form_type":"4"}},{"id":761538,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-27T22:13:08.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":2741,"price":241.57,"value":662143.37,"ownership":{"direct":true},"balance_after":9567,"source":{"system":"sec-edgar","filing":"0001302443-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000008/edgardoc.xml","form_type":"4"}},{"id":761537,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-27T22:13:08.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":true,"shares":3415,"price":138.08,"value":471543.2,"ownership":{"direct":true},"balance_after":12308,"source":{"system":"sec-edgar","filing":"0001302443-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000008/edgardoc.xml","form_type":"4"}},{"id":765590,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-05-22T22:27:58.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":20038,"price":16.55,"value":331628.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1631056,"source":{"system":"sec-edgar","filing":"0001302443-26-000006","document":"form4-05222026_100553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000006/form4-05222026_100553.xml","form_type":"4"}},{"id":815925,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-04-03T22:10:24.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1651094,"source":{"system":"sec-edgar","filing":"0001302443-26-000004","document":"form4-04032026_100419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000004/form4-04032026_100419.xml","form_type":"4"}},{"id":884357,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2026-02-25T00:43:51.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":74975,"price":19.66,"value":1474008.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1576094,"source":{"system":"sec-edgar","filing":"0001302443-26-000002","document":"form4-02252026_120248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000002/form4-02252026_120248.xml","form_type":"4"}},{"id":991145,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-11-22T00:10:33.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":56817,"price":17.9,"value":1017024.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1651069,"source":{"system":"sec-edgar","filing":"0001302443-25-000008","document":"form4-11222025_121129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244325000008/form4-11222025_121129.xml","form_type":"4"}},{"id":991144,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-11-22T00:10:33.000Z","date":"2025-11-19","kind":"gift","planned":false,"acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act (\"UTMA\"), for which the Reporting Person serves as a custodian."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001302443-25-000008","document":"form4-11222025_121129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244325000008/form4-11222025_121129.xml","form_type":"4"}},{"id":991143,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-11-22T00:10:33.000Z","date":"2025-11-19","kind":"gift","planned":false,"acquired":false,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act (\"UTMA\"), for which the Reporting Person serves as a custodian."}],"balance_after":1707886,"source":{"system":"sec-edgar","filing":"0001302443-25-000008","document":"form4-11222025_121129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244325000008/form4-11222025_121129.xml","form_type":"4"}},{"id":992381,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-20T22:54:48.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":5500,"price":180.8597,"value":994728.35,"ownership":{"direct":true},"balance_after":8893,"source":{"system":"sec-edgar","filing":"0001302443-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244325000006/edgardoc.xml","form_type":"4"}},{"id":1057647,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-08-22T22:09:19.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15394,"price":13.39,"value":206125.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1717786,"source":{"system":"sec-edgar","filing":"0001415889-25-022803","document":"form4-08222025_100815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588925022803/form4-08222025_100815.xml","form_type":"4"}},{"id":1069957,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:34:20.000Z","date":"2025-08-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1805,"price":111.2524,"value":200810.582,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":14393,"source":{"system":"sec-edgar","filing":"0001765581-25-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000078/edgardoc.xml","form_type":"4"}},{"id":1069956,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:34:20.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":3507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026."}],"balance_after":16198,"source":{"system":"sec-edgar","filing":"0001765581-25-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000078/edgardoc.xml","form_type":"4"}},{"id":1101583,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-06-25T22:06:00.000Z","date":"2025-06-23","kind":"gift","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Bona Fide Gift. No compensation was given to the donor for the gifting of shares."}],"balance_after":1733180,"source":{"system":"sec-edgar","filing":"0001415889-25-018221","document":"form4-06252025_100657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588925018221/form4-06252025_100657.xml","form_type":"4"}},{"id":1107646,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-06-17T22:16:33.000Z","date":"2025-06-13","kind":"gift","planned":false,"acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act (\"UTMA\"), for which the Reporting Person serves as a custodian."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001415889-25-017585","document":"form4-06172025_100629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588925017585/form4-06172025_100629.xml","form_type":"4"}},{"id":1107645,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-06-17T22:16:33.000Z","date":"2025-06-13","kind":"gift","planned":false,"acquired":false,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act (\"UTMA\"), for which the Reporting Person serves as a custodian."}],"balance_after":1753180,"source":{"system":"sec-edgar","filing":"0001415889-25-017585","document":"form4-06172025_100629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588925017585/form4-06172025_100629.xml","form_type":"4"}},{"id":1136827,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-05-22T22:44:56.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15364,"price":9.45,"value":145189.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1762780,"source":{"system":"sec-edgar","filing":"0001415889-25-014263","document":"form4-05222025_100552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588925014263/form4-05222025_100552.xml","form_type":"4"}},{"id":1227243,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-03-04T23:17:21.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":2178,"price":9.35,"value":20364.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on February 28, 2025."}],"balance_after":1778144,"source":{"system":"sec-edgar","filing":"0001415889-25-006684","document":"form4-03042025_110318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588925006684/form4-03042025_110318.xml","form_type":"4"}},{"id":1249207,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2025-02-25T00:32:45.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":35129,"price":9.66,"value":339346.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1775966,"source":{"system":"sec-edgar","filing":"0001415889-25-005357","document":"form4-02252025_120241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588925005357/form4-02252025_120241.xml","form_type":"4"}},{"id":1353973,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-22T23:10:49.000Z","date":"2024-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15997,"price":9.97,"value":159490.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1811095,"source":{"system":"sec-edgar","filing":"0001415889-24-027573","document":"form4-11222024_111145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924027573/form4-11222024_111145.xml","form_type":"4"}},{"id":1358681,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-11-20T02:08:38.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":3193,"price":9.57,"value":30557.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction is being reported late due to inadvertent administrative error. Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on November 14, 2024. Transaction was with the Issuer and did not involve an open market transaction."}],"balance_after":1827092,"source":{"system":"sec-edgar","filing":"0001415889-24-027297","document":"form4-11202024_021133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924027297/form4-11202024_021133.xml","form_type":"4"}},{"id":1425095,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-08-23T00:09:10.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15997,"price":8.22,"value":131495.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1823899,"source":{"system":"sec-edgar","filing":"0001415889-24-022092","document":"form4-08232024_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924022092/form4-08232024_120807.xml","form_type":"4"}},{"id":1436764,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-08-09T22:05:14.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":3252,"price":7.83,"value":25463.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on August 7, 2024. Transaction was with the Issuer and did not involve an open market transaction."}],"balance_after":1839896,"source":{"system":"sec-edgar","filing":"0001415889-24-021057","document":"form4-08092024_100810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924021057/form4-08092024_100810.xml","form_type":"4"}},{"id":1439508,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T22:42:37.000Z","date":"2024-08-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1484,"price":111.35,"value":165243.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":12691,"source":{"system":"sec-edgar","filing":"0001765581-24-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000079/edgardoc.xml","form_type":"4"}},{"id":1439507,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T22:42:37.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":3731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025."}],"balance_after":14175,"source":{"system":"sec-edgar","filing":"0001765581-24-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000079/edgardoc.xml","form_type":"4"}},{"id":1505211,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-05-22T22:10:21.000Z","date":"2024-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15997,"price":9.1,"value":145572.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1836644,"source":{"system":"sec-edgar","filing":"0001415889-24-014141","document":"form4-05222024_100514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924014141/form4-05222024_100514.xml","form_type":"4"}},{"id":1510852,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-05-17T22:01:45.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":2068,"price":9.85,"value":20369.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on May 15, 2024. Transaction was with the Issuer and did not involve an open market transaction."}],"balance_after":1852641,"source":{"system":"sec-edgar","filing":"0001415889-24-013612","document":"form4-05172024_100519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924013612/form4-05172024_100519.xml","form_type":"4"}},{"id":1547673,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-04-04T22:17:33.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 2, 2024, the reporting person was granted 300,000 RSUs. 150,000 RSUs are subject to service-based vesting conditions and the remaining 150,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment."}],"balance_after":1850573,"source":{"system":"sec-edgar","filing":"0001415889-24-010328","document":"form4-04042024_100427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924010328/form4-04042024_100427.xml","form_type":"4"}},{"id":1568001,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-03-19T22:06:26.000Z","date":"2024-03-15","kind":"gift","planned":false,"acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act (\"UTMA\"), for which the Reporting Person serves as a custodian."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose."}],"balance_after":3900,"source":{"system":"sec-edgar","filing":"0001415889-24-008630","document":"form4-03192024_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924008630/form4-03192024_100308.xml","form_type":"4"}},{"id":1568000,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-03-19T22:06:26.000Z","date":"2024-03-15","kind":"gift","planned":false,"acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act (\"UTMA\"), for which the Reporting Person serves as a custodian."}],"balance_after":1550573,"source":{"system":"sec-edgar","filing":"0001415889-24-008630","document":"form4-03192024_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924008630/form4-03192024_100308.xml","form_type":"4"}},{"id":1567999,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-03-19T22:06:26.000Z","date":"2024-03-15","kind":"gift","planned":false,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Bona Fide Gift. No compensation was given to the donor for the gifting of shares."}],"balance_after":1554473,"source":{"system":"sec-edgar","filing":"0001415889-24-008630","document":"form4-03192024_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924008630/form4-03192024_100308.xml","form_type":"4"}},{"id":1567998,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-03-19T22:06:26.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":2704,"price":8.64,"value":23362.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on March 15, 2024. Transaction was with the Issuer and did not involve an open market transaction."}],"balance_after":1561473,"source":{"system":"sec-edgar","filing":"0001415889-24-008630","document":"form4-03192024_100308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924008630/form4-03192024_100308.xml","form_type":"4"}},{"id":1624994,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-02-23T01:14:41.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":37196,"price":8.92,"value":331788.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1558769,"source":{"system":"sec-edgar","filing":"0001415889-24-004968","document":"form4-02232024_010235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588924004968/form4-02232024_010235.xml","form_type":"4"}},{"id":1730948,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-11-22T23:16:15.000Z","date":"2023-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15804,"price":10.37,"value":163887.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1595965,"source":{"system":"sec-edgar","filing":"0001415889-23-015454","document":"form4-11222023_111107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588923015454/form4-11222023_111107.xml","form_type":"4"}},{"id":1799512,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-08-22T22:19:19.000Z","date":"2023-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15804,"price":9.7,"value":153298.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1611769,"source":{"system":"sec-edgar","filing":"0001415889-23-012522","document":"form4-08222023_100811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588923012522/form4-08222023_100811.xml","form_type":"4"}},{"id":1807130,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T22:08:06.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":1241,"price":138.1584,"value":171454.5744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.77 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":10444,"source":{"system":"sec-edgar","filing":"0001765581-23-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000094/edgardoc.xml","form_type":"4"}},{"id":1807129,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T22:08:06.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":3075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024."}],"balance_after":11685,"source":{"system":"sec-edgar","filing":"0001765581-23-000094","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000094/edgardoc.xml","form_type":"4"}},{"id":1880846,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-05-23T23:48:27.000Z","date":"2023-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":15804,"price":11.21,"value":177162.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1627573,"source":{"system":"sec-edgar","filing":"0001415889-23-008676","document":"form4-05232023_110517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588923008676/form4-05232023_110517.xml","form_type":"4"}},{"id":1972419,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-03-04T01:41:13.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2023, the reporting person was granted 330,000 RSUs.  165,000 RSUs are subject to service-based vesting conditions and the remaining 165,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment."}],"balance_after":1643377,"source":{"system":"sec-edgar","filing":"0001415889-23-004277","document":"form4-03042023_010303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588923004277/form4-03042023_010303.xml","form_type":"4"}},{"id":1999124,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2023-02-23T00:29:45.000Z","date":"2023-02-20","kind":"tax_withholding","acquired":false,"shares":37420,"price":10.44,"value":390664.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1313377,"source":{"system":"sec-edgar","filing":"0001415889-23-003078","document":"form4-02232023_120232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588923003078/form4-02232023_120232.xml","form_type":"4"}},{"id":2083462,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2022-12-17T00:36:34.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":50000,"price":11.19,"value":559500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices from $11.17 to $11.235 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1350797,"source":{"system":"sec-edgar","filing":"0001415889-22-012648","document":"form4-12172022_121226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922012648/form4-12172022_121226.xml","form_type":"4"}},{"id":2083461,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2022-12-17T00:36:34.000Z","date":"2022-12-13","kind":"gift","acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Bona Fide Gift. No compensation was given to the donor for the gifting of shares."}],"balance_after":1400797,"source":{"system":"sec-edgar","filing":"0001415889-22-012648","document":"form4-12172022_121226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922012648/form4-12172022_121226.xml","form_type":"4"}},{"id":2106710,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2022-11-22T21:09:31.000Z","date":"2022-11-20","kind":"tax_withholding","acquired":false,"shares":15804,"price":10.85,"value":171473.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 817 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2022."}],"balance_after":1409797,"source":{"system":"sec-edgar","filing":"0001415889-22-011673","document":"form4-11222022_091120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922011673/form4-11222022_091120.xml","form_type":"4"}},{"id":2175961,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2022-08-23T23:03:55.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":15804,"price":9.34,"value":147609.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1424784,"source":{"system":"sec-edgar","filing":"0001415889-22-008985","document":"form4-08232022_040838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922008985/form4-08232022_040838.xml","form_type":"4"}},{"id":2190640,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:52:46.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":1089,"price":152.3226,"value":165879.3114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":8610,"source":{"system":"sec-edgar","filing":"0001765581-22-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000102/edgardoc.xml","form_type":"4"}},{"id":2190639,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:52:46.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023."}],"balance_after":9699,"source":{"system":"sec-edgar","filing":"0001765581-22-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000102/edgardoc.xml","form_type":"4"}},{"id":2257890,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2022-05-24T23:19:11.000Z","date":"2022-05-20","kind":"tax_withholding","acquired":false,"shares":11025,"price":8.74,"value":96358.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,313 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2022."}],"balance_after":1440588,"source":{"system":"sec-edgar","filing":"0001415889-22-005633","document":"form4-05242022_040502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922005633/form4-05242022_040502.xml","form_type":"4"}},{"id":2364726,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Share Option (Right to Buy)","published_at":"2022-03-02T00:18:23.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":515000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option may be exercised when the optionee completes 12 months of continuous Service after the Date of Grant. Any remaining unvested shares may be exercised with respect to an additional 1/48th of the shares subject to the option when the optionee completes each month of continuous Service thereafter."}],"balance_after":515000,"derivative":{"exercise_price":10.24,"expiration_date":"2032-02-24","underlying":"Ordinary Shares","underlying_shares":515000},"source":{"system":"sec-edgar","filing":"0001415889-22-002078","document":"form4-03012022_040310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922002078/form4-03012022_040310.xml","form_type":"4"}},{"id":2364725,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2022-03-02T00:18:23.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1449300,"source":{"system":"sec-edgar","filing":"0001415889-22-002078","document":"form4-03012022_040310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922002078/form4-03012022_040310.xml","form_type":"4"}},{"id":2377854,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2022-02-23T23:38:18.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":22710,"price":9.61,"value":218243.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1279300,"source":{"system":"sec-edgar","filing":"0001415889-22-001703","document":"form4-02232022_030205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588922001703/form4-02232022_030205.xml","form_type":"4"}},{"id":2497444,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2021-11-24T01:20:11.000Z","date":"2021-11-19","kind":"tax_withholding","acquired":false,"shares":11404,"price":8.36,"value":95337.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1302010,"source":{"system":"sec-edgar","filing":"0001415889-21-005463","document":"form4-11232021_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000141588921005463/form4-11232021_051101.xml","form_type":"4"}},{"id":2592065,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-24T23:05:33.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":11404,"price":14.05,"value":160226.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":1313414,"source":{"system":"sec-edgar","filing":"0001179110-21-008404","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911021008404/edgar.xml","form_type":"4"}},{"id":2608308,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-10T21:42:02.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":1306,"price":147.96,"value":193235.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":7138,"source":{"system":"sec-edgar","filing":"0001765581-21-000112","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000112/edgardoc.xml","form_type":"4"}},{"id":2619826,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-02T22:29:51.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":2246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022."}],"balance_after":8444,"source":{"system":"sec-edgar","filing":"0001765581-21-000087","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000087/edgardoc.xml","form_type":"4"}},{"id":2698447,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-24T22:19:33.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":11404,"price":17.8,"value":202991.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021."}],"balance_after":1324818,"source":{"system":"sec-edgar","filing":"0001179110-21-005852","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911021005852/edgar.xml","form_type":"4"}},{"id":2838697,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-23T23:17:55.000Z","date":"2021-02-20","kind":"tax_withholding","acquired":false,"shares":110348,"price":18.79,"value":2073438.92,"ownership":{"direct":true},"balance_after":1334821,"source":{"system":"sec-edgar","filing":"0001179110-21-002176","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911021002176/edgar.xml","form_type":"4"}},{"id":2868739,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-10T22:53:31.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1445169,"source":{"system":"sec-edgar","filing":"0001179110-21-001541","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911021001541/edgar.xml","form_type":"4"}},{"id":2967718,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-24T23:24:21.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":13946,"price":17.21,"value":240010.66,"ownership":{"direct":true},"balance_after":1275169,"source":{"system":"sec-edgar","filing":"0001179110-20-011377","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911020011377/edgar.xml","form_type":"4"}},{"id":3048511,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-24T22:36:24.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":13946,"price":18.22,"value":254096.12,"ownership":{"direct":true},"balance_after":1289115,"source":{"system":"sec-edgar","filing":"0001179110-20-009275","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911020009275/edgar.xml","form_type":"4"}},{"id":3063274,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-10T20:57:18.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":6765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in full on July 30, 2021."}],"balance_after":6765,"derivative":{"exercise_price":127.07,"expiration_date":"2030-08-05","underlying":"Ordinary Shares","underlying_shares":6765},"source":{"system":"sec-edgar","filing":"0001765581-20-000085","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000085/edgardoc.xml","form_type":"4"}},{"id":3063273,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-10T20:57:18.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":931,"price":125.8699,"value":117184.8769,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6198,"source":{"system":"sec-edgar","filing":"0001765581-20-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000085/edgardoc.xml","form_type":"4"}},{"id":3063272,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-10T20:57:18.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":2705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2021."}],"balance_after":7129,"source":{"system":"sec-edgar","filing":"0001765581-20-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000085/edgardoc.xml","form_type":"4"}},{"id":3136780,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-22T22:13:20.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":13946,"price":26.67,"value":371939.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,402 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2020."}],"balance_after":1303061,"source":{"system":"sec-edgar","filing":"0001179110-20-006535","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911020006535/edgar.xml","form_type":"4"}},{"id":3252653,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-25T00:15:20.000Z","date":"2020-02-20","kind":"tax_withholding","acquired":false,"shares":96850,"price":25.9,"value":2508415.0,"ownership":{"direct":true},"balance_after":1315605,"source":{"system":"sec-edgar","filing":"0001179110-20-002156","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911020002156/edgar.xml","form_type":"4"}},{"id":3288341,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-06T00:06:28.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":168000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 3, 2020, the performance conditions applicable to 168,000 shares were achieved and such shares will vest on February 20, 2021, subject to the reporting person's continued service."}],"balance_after":1412455,"source":{"system":"sec-edgar","filing":"0001179110-20-001210","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911020001210/edgar.xml","form_type":"4"}},{"id":3288340,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-06T00:06:28.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1244455,"source":{"system":"sec-edgar","filing":"0001179110-20-001210","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911020001210/edgar.xml","form_type":"4"}},{"id":3361053,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-22T23:26:47.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":8678,"price":17.6,"value":152732.8,"ownership":{"direct":true},"balance_after":1074455,"source":{"system":"sec-edgar","filing":"0001179110-19-012023","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911019012023/edgar.xml","form_type":"4"}},{"id":3430868,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-22T22:07:39.000Z","date":"2019-08-20","kind":"tax_withholding","acquired":false,"shares":8678,"price":21.51,"value":186663.78,"ownership":{"direct":true},"balance_after":1083133,"source":{"system":"sec-edgar","filing":"0001179110-19-009798","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911019009798/edgar.xml","form_type":"4"}},{"id":3440888,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-12T21:48:09.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":4805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019."}],"balance_after":4805,"derivative":{"exercise_price":137.12,"expiration_date":"2029-08-07","underlying":"Ordinary Shares","underlying_shares":4805},"source":{"system":"sec-edgar","filing":"0001765581-19-000080","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000080/edgardoc.xml","form_type":"4"}},{"id":3440887,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-08-12T21:48:09.000Z","date":"2019-08-09","kind":"sale","acquired":false,"shares":726,"price":135.6504,"value":98482.1904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.65 to $135.7285. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":4424,"source":{"system":"sec-edgar","filing":"0001765581-19-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000080/edgardoc.xml","form_type":"4"}},{"id":3440886,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-08-12T21:48:09.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":1920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2020."}],"balance_after":5150,"source":{"system":"sec-edgar","filing":"0001765581-19-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000080/edgardoc.xml","form_type":"4"}},{"id":3514841,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-22T22:17:16.000Z","date":"2019-05-20","kind":"tax_withholding","acquired":false,"shares":8678,"price":19.84,"value":172171.52,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019."}],"balance_after":1091811,"source":{"system":"sec-edgar","filing":"0001179110-19-006538","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911019006538/edgar.xml","form_type":"4"}},{"id":3638382,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-22T23:25:36.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":13477,"price":27,"value":363879.0,"ownership":{"direct":true},"balance_after":1099462,"source":{"system":"sec-edgar","filing":"0001179110-19-002433","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911019002433/edgar.xml","form_type":"4"}},{"id":3670133,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-07T22:50:49.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":147000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 5, 2019, the performance conditions applicable to 147,000 shares were achieved and such shares will vest on February 20, 2020, subject to the reporting person's continued service."}],"balance_after":1112939,"source":{"system":"sec-edgar","filing":"0001179110-19-001572","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911019001572/edgar.xml","form_type":"4"}},{"id":3670132,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-07T22:50:49.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":965939,"source":{"system":"sec-edgar","filing":"0001179110-19-001572","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911019001572/edgar.xml","form_type":"4"}},{"id":3673864,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-02-05T22:22:38.000Z","date":"2018-08-24","kind":"gift","acquired":false,"shares":1720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares that the Reporting Person donated as a gift to the Fidelity Investment Charitable Gift Fund, a donor advised fund."}],"balance_after":3230,"source":{"system":"sec-edgar","filing":"0000899243-19-002650","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000089924319002650/doc5.xml","form_type":"5"}},{"id":3754334,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2018-11-21T22:47:38.000Z","date":"2018-11-20","kind":"tax_withholding","acquired":false,"shares":15557,"price":24.79,"value":385658.03,"ownership":{"direct":true},"balance_after":795939,"source":{"system":"sec-edgar","filing":"0001179110-18-013111","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911018013111/edgar.xml","form_type":"4"}},{"id":3835711,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-22T23:35:04.000Z","date":"2018-08-20","kind":"tax_withholding","acquired":false,"shares":15557,"price":26.95,"value":419261.15,"ownership":{"direct":true},"balance_after":904063,"source":{"system":"sec-edgar","filing":"0001179110-18-010823","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911018010823/edgar.xml","form_type":"4"}},{"id":3846015,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":3735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018."}],"balance_after":3735,"derivative":{"exercise_price":177.73,"expiration_date":"2028-08-08","underlying":"Ordinary Shares","underlying_shares":3735},"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846014,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This non-qualified stock option was granted on August 8, 2013 and vested over a period of one year from September 1, 2013. The options were fully vested as of August 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":81.76,"expiration_date":"2023-08-07","underlying":"Ordinary Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846013,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This non-qualified stock option was granted on August 9, 2012 and vested over a period of one year from the grant date. The options were fully vested as of August 9, 2013."}],"balance_after":0,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846012,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-10","kind":"sale","acquired":false,"shares":660,"price":176.6108,"value":116563.128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.61 to $177.1555, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":4950,"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846011,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":3437,"price":176.0301,"value":605015.4537,"ownership":{"direct":true},"balance_after":5610,"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846010,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":3542,"price":176.3075,"value":624481.165,"ownership":{"direct":true},"balance_after":9047,"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846009,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":1495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 2, 2019."}],"balance_after":12589,"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846008,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":9000,"price":176.149,"value":1585341.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.14 to $176.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":11094,"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846007,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":4500,"price":46.83,"value":210735.0,"ownership":{"direct":true},"balance_after":20094,"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3846006,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:05:56.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":4500,"price":81.76,"value":367920.0,"ownership":{"direct":true},"balance_after":15594,"source":{"system":"sec-edgar","filing":"0001232524-18-000136","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000136/edgardoc.xml","form_type":"4"}},{"id":3883963,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-25T18:07:27.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of the shares subject thereto upon the earlier of one year following the grant date or the date of the subsequent year's annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.55,"expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-18-029837","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036118029837/doc1.xml","form_type":"4"}},{"id":3921756,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-22T23:03:09.000Z","date":"2018-05-20","kind":"tax_withholding","acquired":false,"shares":67617,"price":24.31,"value":1643769.27,"ownership":{"direct":true},"balance_after":919620,"source":{"system":"sec-edgar","filing":"0001179110-18-007376","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000117911018007376/edgar.xml","form_type":"4"}}],"next_cursor":"2018-05-22T23:03:09.000000Z,3921756"}